Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (1074)	11/18/1998 4:54:00 PM
From: Anthony Wong	Respond to of 1722

Viagra Sets French Record for Sales of New Drug in 1st 3 Weeks Bloomberg News November 18, 1998, 3:57 a.m. ET Paris, Nov. 18 (Bloomberg) -- Pfizer's impotence drug Viagra has set a record for sales of a new drug in France in the first three weeks of its launch, beating the anti- depressant Prozac, said Liberation, citing Alain Jardin, the Head of Urology at Kremlin-Bicetre in Val-de-Marne, southeast of Paris. By Nov. 7, three weeks after its debut in French pharmacies, Pfizer said it sold 40,000 pills, corresponding to 34,000 medical prescriptions. General Practitioners prescribed 75 percent, with specialists, mainly urologists, prescribing the remainder, the report said. Viagra, which is available in French pharmacies at 75 francs ($13) per pill, is not refunded by French social security and is available only on prescription to men over the age of 18 in dosages of 25, 50 and 100mg. (Liberation, 11/18, www.liberation.com) --Didier Carcone and Simon Packard in the Paris newsroom (331)